null

Milatuzumab Biosimilar (Anti-CD74) Antibody (HDBS0152)

SKU:
HDBS0152
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CD74
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399
Frequently bought together:

Description

system_update_altDatasheet

Milatuzumab (Anti-CD74) Biosimilar Antibody (HDBS0152)

The Milatuzumab Biosimilar Anti-CD74 Antibody is a unique product designed for research involving CD74, a cell surface protein involved in immune regulation and antigen presentation. This antibody, produced using state-of-the-art technology, specifically targets the CD74 protein and is highly reactive with human samples.CD74 plays a crucial role in immune responses by facilitating the presentation of antigens to immune cells, thereby initiating immune responses. Research into CD74 is essential for understanding immune system function and developing therapies for autoimmune diseases, cancer, and infectious diseases.

The Milatuzumab Biosimilar Anti-CD74 Antibody is validated for various applications, including Western blotting and immunofluorescence, making it a versatile tool for studying CD74 expression and function in different cell types. Its high specificity and sensitivity make it an ideal choice for researchers in immunology, oncology, and drug development seeking to explore the role of CD74 in immune responses and disease progression.

Product Name:Milatuzumab (Anti-CD74) Biosimilar Antibody
Size:100 ug
Product SKU:HDBS0152
Target:CD74
Host Species:Humanized
Reactivity:Human
Recommended Dilution:Flow Cyt 1:100
Antibody Type:Monoclonal
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:CD74-DOX (ADC),hLL1,hLL1-DOX (ADC),MEDI-115
Description:Anti-CD74(milatuzumab biosimilar) mAb
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:Powder
ApplicationsFlow Cyt
Antibody Isotype:IgG1
Guarantee:12 months from date of dispatch
Background:Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Synonyms:DHLAG
Uniprot:P04233

Related Products